Trade STRO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Sutro Biopharma, Inc. (STRO) is trading at US$20.56, down 3.54% today as of Aug 28, 12:22 EDT. The company has a market capitalisation of US$348.87M. Over the past 52 weeks, STRO has traded between US$7.15 and US$43.85. On Syfe you can trade STRO with $0 commission and add it to your watchlist.
| Previous close | US$21.31 |
|---|---|
| Market cap | US$348.87M |
| 52-week range | US$7.15 – US$43.85 |
| Volume | 92.13K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Sutro Biopharma, Inc.
Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
Year: 2018
Barclays Initiates Sutro Biopharma at Overweight With $56 Price Target
May 28, 11:24 AM · MT Newswires
Update: Sutro Biopharma Shares Rise After Q1 Loss Narrows
May 15, 6:54 PM · MT Newswires
Wedbush Upgrades Sutro Biopharma to Outperform From Neutral, Boosts Price Target to $60 From $22
May 15, 10:33 AM · MT Newswires
Mizuho Initiates Sutro Biopharma at Outperform With $50 Price Target
Apr 30, 10:44 AM · MT Newswires
Leerink Partners Initiates Sutro Biopharma at Outperform With $38 Price Target
Apr 7, 11:15 AM · MT Newswires
Sutro Biopharma, Inc. (STRO) stock is trading at US$20.56, -3.54% from the previous close of US$21.31.
The market cap for Sutro Biopharma, Inc. (STRO) stock is approximately US$348.87M.
The 52-week high for Sutro Biopharma, Inc. (STRO) stock is US$43.85.
The 52-week low for Sutro Biopharma, Inc. (STRO) stock is US$7.15.
Sutro Biopharma, Inc. (STRO) does not currently pay a dividend.
Stay on top of STRO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
